Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FRG-8813

Known as: FRG 8813 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
We investigated the recurrence of ulcers in rats after treatment with FRG-8813, (±)-2-(furfurylsulfinyl)-N-[4- [4… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1999
1999
Lafutidine (CAS 118288-08-7, FRG-8813) is a novel histamine H2-receptor antagonist with gastroprotective activity. The aim of… Expand
Is this relevant?
1996
1996
Certain chemical properties, which may determine the stimulatory actions of the new histamine H2 receptor antagonist, FRG-8813 (2… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
FRG-8813 ((+/-)-2-(furfurylsulfinyl)-N-[4-[4-(piperidinomethyl)-2- pyridyl]oxy-(Z)-2-butenyl]acetamide) is a novel histamine H2… Expand
Is this relevant?
1995
1995
The present study was conducted to investigate the histamine H2-receptor antagonistic property of FRG-8813 by using isolated… Expand
Is this relevant?
1995
1995
We examined the effect of FRG-8813, a new histamine H2-receptor antagonist, on 1% NH3-induced gastric mucosal lesions and basal… Expand
Is this relevant?
1994
1994
It is not presently well understood whether the histamine H2 receptor antagonist has a function other than the inhibition of… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
FRG-8813, a new histamine H2 receptor antagonist, was examined for antisecretory effects and compared with famotidine and… Expand
Is this relevant?
1992
1992
We examined the anti-ulcer effects of FRG-8813, a new type histamine H2-receptor antagonist, on various experimental gastric and… Expand
Is this relevant?
1992
1992
We examined the anti-ulcer effects of FRG-8813, a new-type histamine H2-receptor antagonist, in chronic ulcer models of rats and… Expand
Is this relevant?